2019 AVBCC Summit Agenda

Take a look at the exciting lineup for the 2019 Summit! Sessions feature experts and respected faculty from across the field. This is a must-attend event for all stakeholders in the cancer-care value equation. Book your spot today!

Place your cursor over a faculty member to learn more.

2019 Summit Agenda

• Tuesday, October 15
• Wednesday, October 16
• Thursday, October 17
• Friday, October 18

• Tuesday, October 15
  6:00pm – 8:00pm	Professional Development Invitational Faculty Dinner

• Wednesday, October 16
  7:45am – 9:00am	Pre-Summit Professional Development Workshops – Registration
  9:00am – 10:15am	Professional Workshop 1 Working with Integrated Health Delivery Systems in Cancer Care Ecosystem Moderator: Barry Brooks, MD Faculty: Myla Maloney, MBA, BCMAS Chris Byrne Tara Herington, RN Niesha Griffith, RPh, MS, FASHP John Sprandio, MD, FACP Rob Hauser, PharmD, PhD Marc Earl, PharmD, BCOP
  10:15am – 11:30am	Professional Workshop 2 Information Technologies, Artificial Intelligence, Pathways and Order Set, and Their Influence and Challenges in Cancer Care Data Information Needs for the Cancer Care Ecosystem Stakeholders Moderator: William McGivney, PhD Faculty: David Waterhouse, MD, MPH Marc Earl, PharmD, BCOP Susan Weidner, MBA Jeffrey Scott, MD William Flood, MD Andrew Hertler, MD, FACP James Hamrick, MD, MPH Aaron Lyss, MBA Brian Bourbeau, MBA Ira Klein, MD, MBA, FACP John Sprandio, MD, FACP
  11:30am – 12:30pm	Professional Workshop 3 Topical Legal Issues in Cancer Care Big Data and Oncology Control of Data Updates from the Front Lines of PBM Battles Legal Considerations in Value Based Contracting Moderator: Jayson Slotnik, JD, MPH Faculty: Daniel Frier, JD Jonathon Levitt, JD Lili Brillstein, MPH
  12:30pm – 1:30pm	Luncheon and Panel Discussion Navigating Future Innovation and Legacy Challenges to the US Cancer Markets Ahead Moderator: William McGivney, PhD Faculty: Aaron Lyss, MBA Jeffrey Scott, MD Gregory Simon, JD Patricia Goldsmith Ira Klein, MD, MBA, FACP
  1:30pm – 2:30pm	Professional Workshop 4 Pharmacy’s Emerging Influence and the Roles They Play Over Drug/Biologic Access and Impact on Cancer Care Moderator: Niesha Griffith, RPh, MS, FASHP Faculty: Ali McBride, PharmD, MBA Ray Bailey, BPharm, RPh Steven D’Amato, RPh, BSPharm, BCOP Michael Reff, RPh, MBA Chris Byrne Rob Hauser, PharmD, PhD Kate Jeffers, PharmD, MHA, BCOP Marc Earl, PharmD, BCOP
  2:30pm – 5:00pm	Professional Workshop 5 Value Positioning and Pricing for Cancer Drugs/Biologics and Technologies in the Real World and Perspectives in Cancer Care Value-Based Contracting: The Application, Mechanics, and Simulation in the Real World for Negotiating Value and Performance Moderator: Jeff Berkowitz, JD Faculty: Larry Blandford, PharmD Tesh Khullar, MBA Ira Klein, MD, MBA, FACP Charles Stevens, JD, MBA Scott Kornhauser Jeffrey Scott, MD Rusty Massey
  5:00pm – 6:00pm	Networking Reception

• Thursday, October 17
  6:30am – 8:00am	Summit Registration
  7:30am – 8:15am	Session 1 Real-World Noise, Trends, Realities, and Implications on the Road to Value-Based Contracting in Cancer Care Moderator: William McGivney, PhD Faculty: Jeff Berkowitz, JD Barry Brooks, MD Jeffrey Scott, MD Jeffrey Patton, MD Tesh Khullar, MBA Ira Klein, MD, MBA, FACP John Doyle, PhD
  8:15am – 9:00am	Keynote An Insider to Outsider’s Look at the Future of Cancer Care Delivery Speaker: Lee Newcomer, MD
  9:00am – 9:45am	Session 2 Washington and the Cancer Care Value Perspectives Moderator: Jayson Slotnik, JD, MPH Faculty: Blair Childs Gregory Simon, JD Brad Tallamy Ben Jones Barrett Thornhill, JD
  9:45am – 10:30am	Session 3 Employers and the Cancer Care Value Perspectives Moderator: Arthur Taft, MBA Faculty: Michelle Martin Michael Thompson Eslyn Byarm, RN, BSN, CCM, AATMC F. Randy Vogenberg, PhD
  10:30am – 11:15am	Session 4 Insurance Payers and the Cancer Care Value Perspectives Moderator: Mike Kolodziej, MD Faculty: Surya Singh, MD William Winkenwerder, Jr, MD Scott Breidbart, MD Kent Rogers, MBA Steven Peskin, MD Bryan Loy, MD, MBA Bob McDonough, MD
  11:15am – 12:00pm	Session 5 Community Cancer Care and the Value Perspective Moderator: Barry Brooks, MD Faculty: Aaron Lyss, MBA David Waterhouse, MD, MPH Nicolas Ferreyros Russell Gollard, MD Jeffrey Scott, MD Lee Schwartzberg, MD, FACP Bryan Loy, MD, MBA
  12:00pm – 12:45pm	Session 6 Cancer Centers and the Integrated Health Delivery Systems and the Cancer Care Value Perspectives Moderator: William McGivney, PhD Faculty: Christian Downs, MHA, JD Pat Basu, MD, MBA Myla Maloney, MBA, BCMAS Al Benson III, MD, FACP, FASCO Niesha Griffith, RPh, MS, FASHP Marc Earl, PharmD, BCOP
  1:15pm – 2:00pm	Session 7 Biotech and Pharmaceutical Developers’ Perspectives on the Value Innovation Is Delivering to Stakeholders in Cancer Care Moderator: William McGivney, PhD Faculty: Michael Valenta Alex Santini Eric Dozier Mitch Higashi Don Sawyer
  2:00pm – 2:45pm	Keynote Opinions and Thoughts on the Future of Cancer Care in America Speaker: Scott Gottlieb, MD
  2:45pm – 3:45pm	Key Opinion Leader Session 1 From Innovation to Commercialization: Are Manufacturers and Other Key Cancer Therapy Development Stakeholders Evolving Rapidly Enough to Meet the Clinical and Commercial Demands for New, More Efficacious Therapies? Moderator: Morrie Ruffin Faculty: Brian Leyland-Jones, BSc, MBBS, PhD, FRACP, FRCPC Gregory MacMichael, PhD Kimberly Noonan Kristi Jones Amy DuRoss Michele Korfin Key Opinion Leader Session 2 Liquid Biopsy: Clinical–Economic Considerations for Value-Based Healthcare Moderator: Stan Skrzypczak, MS, MBA Faculty: Bob Li, MD, MPH Lee Schwartzberg, MD, FACP Rick Lanman, MD Mark Hiatt, MD Bob McDonough, MD Key Opinion Leader Session 3 Establishing Cancer Care Coordination Processes and Standardization for Oncology Nurse Navigators Moderator: Sharon Gentry, MSN, RN, AOCN, CBCN, HON-ONN-CG Faculty: Mary Rivera, RN, AOCNS Anne Ireland, MSN, RN, AOCN Janet Gordils-Perez, DNP, RN, ANP-BC, AOCNP Emily Gentry, RN, BSN, OCN Key Opinion Leader Session 4 Emerging Data Opportunities for Enhancing the Value of Oncology Therapeutics Moderator: Darin Rubin Faculty: Ira Klein, MD, MBA, FACP Joe Baffone Ash Malik, MBA Danielle Ziernicki, PharmD Staurt Genschaw Robert Miller, MD, FACP, FASCO
  3:45pm – 4:45pm	Key Opinion Leader Session 5 Genomics and Personalized Medicine Innovation Value Moderator: Stan Skrzypczak, MS, MBA Faculty: Lee Schwartzberg, MD, FACP Rachel Anhorn, PharmD John Simmons, PhD Edward Abrahams, PhD Gary Palmer, MD, JD, MBA, MPH Rick Lanman, MD James Almas, MD Ted Snelgrove, MBA Key Opinion Leader Session 6 Oncology Drug Supply Chain Channels and the Move to Value Moderator: Bob Charles, MBA Faculty: Niesha Griffith, RPh, MS, FASHP Scott Jauch Mike McCarthy Amy Valley, PharmD, BCOP Matt Outten, MBA, ALM, CPC Mark Hagler Pete Perron Cynthia Radford Marc Earl, PharmD, BCOP Key Opinion Leader Session 7 Legal Headwind and Tailwind Impacting Cancer Patients, Providers, Payers, and Pharma Moderator: Alexis Bortniker, JD Faculty: Jennifer Walsh Adria Warren, JD Key Opinion Leader Session 8 Payers and Value-Based Care Pilots and Innovation Use Cases in Cancer Care Moderator: Pamela Pelizzari, MPH Faculty: Bo Gamble Christian Downs, MHA, JD Dan Renick, RPh John Sprandio, MD, FACP Bob McDonough, MD Bryan Loy, MD, MBA
  4:45pm – 5:45pm	Key Opinion Leader Session 9 Value-Based Contracting Case Studies and What Failed, Worked, and Learned Moderator: Jeff Berkowitz, JD Faculty: Bethanie Stein, PharmD Kent Rogers, MBA Ross Maclean, MD Scott Jauch Jim Clement Key Opinion Leader Session 10 Patient Centricity and Digital Platforms: Cancer Survival Outside of Medicine’s 4 Walls Moderator: Rick Lee, MBA, PhD Faculty: Jeremy Nobel, MD, MPH Charlie Coltman Harry Travis, BS Pharm, MBA Key Opinion Leader Session 11 Biosimilars and Follow-on Technology Value Creation Moderator: Sean McGowan, MBA Faculty: William Yoon, MD Rob Stianchi Chrys Kokino, MBA Neal Lambert Key Opinion Leader Session 12 The Role of ICER as a US-HTA with Payer & Manufacturer and Views on the Level of Influence They Have on Markets Moderator: Charles Stevens, JD, MBA Faculty: Kathryn Lang, MD Kelly Franchetti, RN, CCRN, CEN Jenny Lee, PharmD, MBA, MPH
  5:45pm – 6:30pm	Session 8 Key Cancer Researchers and Their Own Development Perspectives and Experiences Moderator: Neil Canavan Faculty: Rob Hauser, PharmD, PhD Ryan Berube Mimi Schnier Luis Diaz, MD Cliff Hudis, MD Joshua Brody, MD
  6:30pm – 8:30pm	SAA Reception/Auction

• Friday, October 18
  6:30am – 7:30am	Summit Registration
  7:00am – 7:45am	Session 9 Comprehensive Near-Term Oncology Pipeline Overview Covering Oral-Infused-Gene Therapies Moderator: Jeffrey Bockman, PhD Faculty: Cheryl Allen, PharmD, MBA Michael Mong, PharmD
  7:45am – 8:30am	Key Opinion Leader Session 13 Pharma and the Opportunities Ahead for New Innovative Value-Based Contracting Methodologies Moderator: Roger Longman Faculty: Ira Klein, MD, MBA, FACP John Doyle, PhD Scott Jauch Rena Goins Joe Vandigo, MBA, PhD Gerry Gleeson, MBA Key Opinion Leader Session 14 Innovation to Improve Prevention and Diagnosis, and Provide Patient-Centered Value-Based Cancer Care Moderator: Faculty: Cardinale Smith, MD, PhD Kathryn Lang, MD John Sprandio, MD, FACP Gena Cook Judith Gallagher, MBA, PA-C Anil Rustgi, MD Christina Ritter, PhD Key Opinion Leader Session 15 Value of Tele-Health and Digital Technologies in Cancer Care Moderator: Steven Peskin, MD Faculty: Harry Travis, BS Pharm, MBA Bob Gold Pierre Leurent
  8:30am – 9:15am	Keynote Projecting on the Look Ahead as Public Policy and Market Reality Converge Speaker: John O’Brien, PharmD, MPH
  9:15am – 10:15am	Session 10 Value Equations and Real-World Applications in Cancer Care Moderator: William McGivney, PhD Faculty: Peter Bach, MD Kent Rogers, MBA Surya Singh, MD Larry Blandford, PharmD Kathryn Lang, MD John O’Brien, PharmD, MPH
  10:15am – 11:00am	Key Opinion Leader Session 16 Pharmacy Benefit Managers and the Future Role Managing of Cancer Drug Optimization and Value Moderator: Barry Brooks, MD Faculty: Gina Guinasso, JD Mostafa Kamal Benito Fernandez Ross Hoffman, MD Mike Einodshofer, RPh, MBA Surya Singh, MD Key Opinion Leader Session 17 Practice Transformation Embracing Clinical Decision Support Systems and Care Management Processes and Influence on Value-Based Cancer Care Moderator: Mike Kolodziej, MD Faculty: Andrew Norden, MD, MPH, MBA James Hamrick, MD, MPH Lee Schwartzberg, MD, FACP Lalan Wilfong, MD Susan Weidner, MBA Key Opinion Leader Session 18 Cancer Care Behavior Management Program to Increase Human Resiliency to Stay on Therapy and Achieve Quality Measures While Reducing Clinical Fatigue Moderator: Bob Gold Faculty: Steven Peskin, MD Sarah Beadling Deborah Toppmeyer, MD Judith Haber, PhD, APRN, BC, FAAN
  11:00am – 12:15pm	Key Opinion Leader Session 19 Global Oncology Trends Reports, Therapeutics, Clinical Development, and Health System Implications Moderator: Burt Zweigenhaft, BS Faculty: Douglas Long, MBA Michael Kleinrock Key Opinion Leader Session 20 Value-Based Contracting in Cancer Care and the Challenges to Coding, Pricing, and Reimbursement Moderator: Denise Pierce Faculty: Brian Gockerman Gail Airasian, MBA John Sprandio, MD, FACP Ash Malik, MBA Ron DiGiaimo, MBA Key Opinion Leader Session 21 Oncology Nurses and Navigators and Their Expanded Role in the Value Equation Moderator: Andrea Dwyer Faculty: Brenda Nevidjon, MSN, RN, FAAN Danelle Johnston, MSN, RN, HON-ONN-CG, OCN JoAnn Lovins, MS, RN Monica Dean Kendra Barber, MHA, RN, OCN
  12:15pm – 1:00pm	Key Opinion Leader Session 22 Capital Markets Views on Value Cancer Care Moderator: Dennis Purcell, MBA Faculty: Lisa Gill Robert Jones Jonathon Fassberg Dara Lundon Key Opinion Leader Session 23 Oncology Pharmacy and Emerging Role in Integrative Cancer Care Moderator: Niesha Griffith, RPh, MS, FASHP Faculty: Ali McBride, PharmD, MBA Ray Bailey, BPharm, RPh Steven D’Amato, RPh, BSPharm, BCOP Ray Muller, MS, RPh, FASHP Rob Hauser, PharmD, PhD Stacey McCullough, PharmD Key Opinion Leader Session 24 Data Information Needs and Requirements for Future Cancer Care Moderator: Faculty: Marc Earl, PharmD, BCOP Ash Malik, MBA Joel Brill, MD, FACP, AGAF, FASGE, FACG Lalan Wilfong, MD Brian Bourbeau, MBA
  1:15pm – 2:00pm	Key Opinion Leader Session 25 New Access Challenges Facing Cancer Patients and the Future Missions and Initiatives of Advocacy Groups to Ensure Access to Cancer Care Moderator: Gregory Simon, JD Faculty: Gena Cook Patricia Goldsmith Clorinda Walley Rose Gerber Deborah Kamin, RN, PhD Key Opinion Leader Session 26 Oncology Drug Pricing Under Extreme Market Pressures and the Projected Impact on All Stakeholder Channels in the Future Moderator: Gabriela Dieguez, FSA, MAAA Faculty: John O’Brien, PharmD, MPH David Wierz Brian Agnew Key Opinion Leader Session 27 Legal Considerations for Oncology Manufacturers Structuring Value-Based Models Moderator: Faculty: John Morrone, JD Jesse Dresser, JD
  2:00pm – 2:45pm	Key Opinion Leader Session 28 Cancer Care: The Real-World Economics and Value Realities Moderator: Jayson Slotnik, JD, MPH Faculty: Brian DeBusk, PhD, MBA Kathryn Lang, MD Bruce Pyenson, FSA, MAAA Key Opinion Leader Session 29 Artificial Intelligence in Oncology Value-Based Care Moderator: John Frownfelter, MD, FACP Faculty: Amy Ellis Ray Page, DO, PhD, FACOI, FASCO Annastasiah Mhaka, PhD Sibel Blau, MD Eric Schultz Key Opinion Leader Session 30 Palliative Care and the Value Derived in Cancer Care Moderator: Thomas LeBlanc, MD Faculty: Gena Cook Sarah Beadling Torrie Fields, MPH
  2:45pm – 3:30pm	Session 11 Cancer Care Future State and Predictions Moderator: William McGivney, PhD Faculty: Cliff Hudis, MD Lee Newcomer, MD Jeffrey Patton, MD Mike Kolodziej, MD Barry Brooks, MD
  3:30pm – 4:15pm	Closing Reception

*Agenda subject to change.

Return to Top